# Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.

> **NCT05135052** · NA · ACTIVE_NOT_RECRUITING · sponsor: **OncoBeta Therapeutics** · enrollment: 210 (estimated)

## Conditions studied

- Non-melanoma Skin Cancer

## Interventions

- **DEVICE:** Rhenium-SCT

## Key facts

- **NCT ID:** NCT05135052
- **Lead sponsor:** OncoBeta Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-17
- **Primary completion:** 2026-07-15
- **Final completion:** 2027-05-15
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135052, "Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05135052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*